Shoulder arthroplasty procedures are becoming increasingly common. Procedure volumes increased at annual rates of 6% to 13% from 1993 to 2007. Compared with 2007 levels, projected procedures were predicted to further increase by between 192% and 322% by the end of 2015.^[@bibr3-2325967116671501]^ Shoulder arthroplasty remains the third most commonly performed joint replacement behind hip and knee arthroplasty.^[@bibr8-2325967116671501],[@bibr18-2325967116671501],[@bibr22-2325967116671501],[@bibr25-2325967116671501],[@bibr26-2325967116671501]^ Satisfaction after shoulder arthroplasty has been variable, and the risk factors for dissatisfaction have not yet been completely elucidated. Correlations have been established between dissatisfaction and lower improvements in pain, function, and range of motion.^[@bibr6-2325967116671501]^ Brenner et al^[@bibr2-2325967116671501]^ reported 75% satisfaction after shoulder arthroplasty at 11-year follow-up. Similarly, in a long-term follow-up study of shoulder arthroplasty in a younger patient population (\<50 years), the authors found that nearly 50% of patients who underwent either total shoulder arthroplasty or hemiarthroplasty graded their result as unsatisfactory.^[@bibr23-2325967116671501]^

Graves et al^[@bibr5-2325967116671501]^ recently reported that patients with 4 or more reported allergies had less improvement in outcome measures after hip and knee replacement surgery. The authors argued that multiple reported allergies may function as a surrogate for a mental health survey and assist in identifying patients at high risk of having poor postoperative outcomes. Similarly, patient-reported metal allergies are associated with poorer functional outcomes after total knee arthroplasty and worse mental health scores after total hip arthroplasty.^[@bibr16-2325967116671501]^ To our knowledge, no similar study has been performed within the shoulder arthroplasty literature. We hypothesized that patients with multiple reported allergies would have worse outcome measures, range of motion, and satisfaction scores after shoulder arthroplasty procedures.

Methods {#section1-2325967116671501}
=======

Institutional review board approval was obtained for this study. The institutional review board waived the requirement for informed consent due to retrospective design, minimal risks, and general consent for inclusion in research studies at time of treatment. Preoperative evaluation of patients who were candidates for shoulder arthroplasty procedures included baseline visual analog scale (VAS) pain scores, Simple Shoulder Test (SST) scores, and range of motion measures including forward flexion. Range of motion was measured by the primary surgeon using goniometry at each encounter. At the first patient visit and then again on the day of surgery, patients were asked to list any "allergies." Their answers were then recorded into the electronic medical record. At 3 months, 6 months, and all subsequent postoperative office visits, patients were once again asked to provide VAS pain scores, repeat the SST, and undergo an evaluation of the shoulder, including measurement of active forward flexion. Additionally, they were asked to provide a satisfaction score (0-10), with 0 being completely unsatisfied and 10 being completely satisfied.

The cohort for our study included patients who had elective primary anatomic total shoulder arthroplasty by a single surgeon over the course of a 6-year period from 2009 to 2014. We included all patients aged 18 years and older and excluded individuals who were undergoing revision surgery or surgery for a traumatic proximal humerus fracture. We identified 98 patients at our academic institution who met the aforementioned criteria and had at least 180 days of follow-up after their index procedure.

Patient drug allergies were obtained from a review of the electronic medical record systems utilized at our institution (EPIC and Powerchart). Within our hospital system, allergy data can be submitted to the electronic medical record by any provider a patient comes in contact with, and thus, these fields were often populated by their primary care physician and confirmed on their visit to our clinic. Food allergies were excluded. Drug reactions that patients classified as "sensitivities" were not considered as allergies for the purposes of this study.

Statistical analyses were performed using JMP software (version 11.2.1; SAS Institute Inc). Three cohorts were studied: patients with no allergies, patients with a single allergy, and patients with multiple allergies. Baseline demographics were compared between cohorts with chi-square (eg, sex, indication) and analysis of variance (ANOVA) with post hoc Tukey (eg, age, body mass index \[BMI\]) testing. Mean VAS pain, SST, active forward flexion range of motion, and satisfaction scores were compared between cohorts with ANOVA and post hoc Tukey testing. The preoperative, postoperative, and difference (postoperative minus preoperative) means of these metrics were compared in this fashion. An alpha level of 0.05 was used as the threshold of statistical significance.

Results {#section2-2325967116671501}
=======

A total of 98 patients who met the aforementioned criteria were identified; 88.8% (n = 87) of cases had degenerative joint disease as the primary indication. The mean (±SD) follow-up duration was 1.50 ± 0.79 years. Half of patients (50%) were female, and the mean age was 67.7 years at the time of surgery. The majority (52.0%, n = 51) of cases were performed on patients with no reported allergies, 21.4% (n = 21) with a single reported allergy, and 26.5% (n = 26) with multiple reported allergies.

Baseline demographic ANOVA testing did not identify any statistically significant differences in age or BMI between cohorts. The proportion of females was greater with increasing number of allergies (no allergies, 31%; single allergies, 47%; multiple allergies, 88%; Pearson χ^2^ = 22.5; *P* \< .0001). Chi square analysis did not reveal any differences in indication, side, or procedure type between cohorts.

Preoperatively and postoperatively, no statistically significant difference was found between cohorts with respect to SST score, VAS pain score, or active forward flexion. As such, no differences were found between cohorts with respect to change in SST scores, VAS scores, or forward flexion. Additionally, there were no differences in postoperative satisfaction between cohorts. These outcome metrics are summarized in [Table 1](#table1-2325967116671501){ref-type="table"}.

###### 

Pre- and Postoperative Outcome Metrics*^a^*

![](10.1177_2325967116671501-table1)

                    Preoperative         Postoperative        Change                                                                                                                                                             
  ----------------- -------------------- -------------------- -------------------- ----- -------------------- --------------------- -------------------- ----- --------------------- --------------------- --------------------- -----
  SST score         3.6 ± 2.5 (n = 44)   3.2 ± 2.3 (n = 18)   3.5 ± 2.2 (n = 21)   .81   9.2 ± 2.8 (n = 45)   10.2 ± 2.2 (n = 18)   8.8 ± 3.2 (n = 18)   .31   5.5 ± 2.8 (n = 39)    6.6 ± 3.5 (n = 15)    4.8 ± 3.3 (n = 16)    .28
  VAS score         6.1 ± 2.6 (n = 45)   5.8 ± 1.7 (n = 19)   6.7 ± 1.7 (n = 21)   .41   1.6 ± 2.3 (n = 45)   0.6 ± 1.1 (n = 18)    1.4 ± 2.1 (n = 18)   .20   −4.6 ± 3.2 (n = 42)   −5.2 ± 2.3 (n = 17)   −5.8 ± 2.7 (n = 16)   .36
  Forward flexion   109 ± 21 (n = 51)    111 ± 25 (n = 21)    115 ± 24 (n = 25)    .57   158 ± 23 (n = 50)    170 ± 5 (n = 21)      163 ± 23 (n =25)     .07   50 ± 27 (n = 50)      60 ± 25 (n = 21)      49 ± 29 (n = 25)      .34
  Satisfaction      ---                  ---                  ---                        8.7 ± 2.1 (n = 44)   9.6 ± 1.3 (n = 17)    8.9 ± 1.5 (n = 18)   .21   ---                   ---                   ---                   

*^a^*FF, forward flexion; SST, Simple Shoulder Test; VAS, visual analog scale.

Discussion {#section3-2325967116671501}
==========

Shoulder arthroplasty remains a very effective treatment for glenohumeral arthritis, and similar to joint replacement for hip and knee arthritis, excellent outcomes can be achieved.^[@bibr12-2325967116671501]^ Many individuals attain improved outcomes with regard to pain relief and quality-of-life measures. There still remain some individuals, however, who do not achieve the expected improvements. Identifying patients who may be at risk for a poor outcome is becoming increasingly important with the advent of accountable care organizations and as government and insurance companies are moving toward payments based on patient reported satisfaction, among other measures. Dissatisfaction after total shoulder arthroplasty has been previously correlated with diminished improvements in pain, function, and range of motion.^[@bibr6-2325967116671501]^ Additionally, patient-reported metal allergies have been associated with poorer functional and mental health after total knee and hip arthroplasties, respectively.^[@bibr16-2325967116671501]^ It was our hypothesis that individuals in our practice with multiple allergies may be a part of the subset of patients with worse outcome measures. It is important to recognize that many allergies listed in the patient medical records are actually adverse drug reactions and not allergies. An adverse drug reaction is defined as a noxious, unintended, and undesired side effect of a drug that occurs when the drugs are given for prevention, diagnosis, and treatment.^[@bibr14-2325967116671501]^ These were excluded for the purposes of our study in an attempt to study outcomes in patients who truly had drug allergies compared with those without.

The hypothesis that patients with multiple drug allergies may be a risk factor for worse function, pain, range of motion, and satisfaction after shoulder arthroplasty procedures was not demonstrated by this study. Our data suggest that for elective primary anatomic total shoulder arthroplasty, self-reported allergies have no bearing on typical outcome metrics. We did find that females were more likely to demonstrate multiple allergies, which is similar to what has been previously reported in the literature for patients undergoing hip and knee arthroplasty.^[@bibr17-2325967116671501]^ Regardless, their outcomes were no different than that of males in our analysis.

Self-reported allergies and multiple drug intolerance syndrome (a condition defined by having \>3 drug hypersensitivities) have been shown to have a high level of correlation with the presence of depression and anxiety.^[@bibr4-2325967116671501],[@bibr19-2325967116671501]^ Prior analysis within the hip and knee arthroplasty literature have demonstrated that mental well-being significantly predicted self-rated health postoperatively.^[@bibr20-2325967116671501]^ Similarly, patients with psychological distress had worse self-perceived preoperative and postoperative subjective disability but had no difference in objective improvements.^[@bibr9-2325967116671501]^ With these considerations in mind, we had hypothesized that similar to the hip and knee arthroplasty literature, multiple self-reported allergies would correlate with worse outcomes. This, however, was not demonstrated.

So why do allergies have a negative correlation to hip and knee arthroplasty outcomes, but not total shoulder outcomes? We can only speculate based on the data available. Prior observational studies regarding multiple drug intolerance syndrome identified patients with this diagnosis as older, heavier (higher BMI), and more likely female.^[@bibr15-2325967116671501]^ While BMI was not significantly different between cohorts in our analysis, the study by Graves et al^[@bibr5-2325967116671501]^ did not compare BMI as an independent variable, which could allow for potential confounding. If the multiple allergy cohort resembles what is typical based on prior observations, the presence of obesity may explain the worse outcomes identified. While a negative association between obesity and outcomes has been well-established after total hip and knee arthroplasty,^[@bibr1-2325967116671501],[@bibr10-2325967116671501],[@bibr13-2325967116671501],[@bibr21-2325967116671501]^ the correlation is far less obvious after total shoulder arthroplasty.^[@bibr7-2325967116671501],[@bibr11-2325967116671501],[@bibr24-2325967116671501]^

This analysis was limited by its retrospective design, which limited the ability to discern between true drug allergies and mere sensitivities. Nonetheless, the metric of self-reported "allergies" is a variable of interest as well as it may function as a surrogate for mental health surveys. Additionally, the retrospective nature limited the ability to reliably identify the presence of anxiety and/or depression, which although highly associated with self-reported drug allergies, may function as a confounder or effect modifier to the outcomes of interest.

Conclusion {#section4-2325967116671501}
==========

The presence of single or multiple self-reported allergies does not correlate with worse function, satisfaction, pain, or range of motion after elective primary anatomic total shoulder arthroplasty.
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